UPDATE : Monday, September 7, 2020
상단여백
GSK to host drive-thru symposium on respiratory disease
GSK said Friday that it would hold a drive-through symposium at Jamsil Driv...
by Shim Hyun-tai  |  2020-05-08 16:34
라인
‘Roche’s Kadcyla allows early breast cancer patients to continue social life’
Roche Korea obtained additional indication approval for Kadcyla (ingredient...
by Kim Yun-mi  |  2020-05-08 15:51
라인
GC joins global plasma alliance to develop Covid-19 therapy
GC said that it has joined the CoVIg-19 Plasma Alliance, composed of global...
by Lee Han-soo  |  2020-05-08 15:45
라인
Hanmi applies for market launch of Korea’s 1st new bio-drug
Hanmi Pharmaceutical submitted a new drug approval application for Rolontis...
by Lee Han-soo  |  2020-05-08 15:45
라인
Arrest warrant sought for Sillajen’s CEO
Prosecutors have requested a court to issue an arrest warrant for Sillajen ...
by Lee Han-soo  |  2020-05-08 15:43
라인
Daewoong’s BTX sales growth offset by lawsuit expenses
Daewoong Pharmaceutical earned 13.6 billion won ($11.1 million) by exportin...
by Jeong Sae-im  |  2020-05-08 12:01
라인
Abclon’s affibody neutralizes Covid-19 virus
Abclon, a company specializing in antibody therapeutics, said Thursday that...
by Shim Hyun-tai  |  2020-05-07 18:50
라인
ISU Abxis’ US partner gets EU patent for hemophilia B drug
ISU Abxis said that the company’s U.S. partner Catalyst Biosciences has acq...
by Lee Han-soo  |  2020-05-07 11:22
라인
Daewoong confirms 99% cure rate in trial of gastric acid blocker
Daewoong Pharmaceutical said that it has confirmed that fexuprazan, its gas...
by Lee Han-soo  |  2020-05-06 13:54
라인
Anticipation for Korean BTX approval in China grows strong
The pharmaceutical industry is closely watching whether a Korean botulinum ...
by Jeong Sae-im  |  2020-05-06 11:53
라인
JW Pharma launches hemophilia A preventive drug in Korea
JW Pharmaceutical said Wednesday that it has launched Hemlibra (ingredient:...
by Lee Han-soo  |  2020-05-06 11:04
라인
Huons to start trials for BTX in China
Huons Global said that China’s National Medical Products Administration Cen...
by Lee Han-soo  |  2020-05-04 11:30
라인
Boryung to be transformed into anticancer drugmaker
Boryung Pharmaceutical elevated its anticancer headquarters, which were pre...
by Jeong Sae-im  |  2020-05-04 10:37
라인
‘Kisqali can treat premenopausal breast cancer patients without removing ovaries’
“In Asia, where women get breast cancer far younger than in the West, the s...
by Shim Hyun-tai  |  2020-05-01 16:45
라인
Korean drugmakers’ Q1 earnings rose despite Covid-19
Leading domestic pharmaceutical companies recorded robust earnings in the f...
by Jeong Sae-im  |  2020-05-01 14:45
라인
Kolon to return $12.3 million upfront payment to Mundipharma
Kolon Life Science said it would return 15 billion won ($12.3 million) upfr...
by Jeong Sae-im  |  2020-05-01 11:23
라인
GC’s Q1 profit surged amid Covid-19
The GC Group said Wednesday that it recorded 6.1 billion won ($5 million) i...
by Shim Hyun-tai  |  2020-04-29 18:14
라인
Court rejects Medytox’ request to stop administrative order on BTX suspension
A local court has turned down Medytox’s appeal for suspending the execution...
by Jeong Sae-im  |  2020-04-29 17:11
라인
‘Keytruda alone works as first-line therapy for lung cancer’
MSD’s immunotherapy Keytruda (ingredient: pembrolizumab) should be a standa...
by Kim Yun-mi  |  2020-04-29 11:40
라인
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
SillaJen said a combination of its oncolytic viral therapy Pexa-Vec (JX-594...
by Jeong Sae-im  |  2020-04-28 17:35
여백
여백
여백
Back to Top